TILs and Anti-PD1 Therapy: An Alternative Combination Therapy for PDL1 Negative Metastatic Cervical Cancer

Table 1

Patient characteristics ().

Characteristic	No. of patients	%
Age (years)
≥45	45	56.25
<45	35	43.75
Pathological type
Squamous cell	65	81.25
Adenocarcinoma	15	18.75
ECOG PS
0	50	62.50
1	30	37.50
HPV status
Positive	68	85.00
Negative	12	15.00
Size of primary tumor(cm)
≥5	47	58.75
<5	33	41.25
First-line chemotherapy with bevacizumab
Yes	20	25.00
No	60	75.00
Location of metastatic tumors
Lung	55	68.75
Liver	30	37.50
Bone	20	25.00
Lymph node	40	50.00
Peritoneum	35	43.75